JANX
NASDAQ · Biotechnology
Janux Therapeutics Inc
$14.18
-0.37 (-2.51%)
Analyst Consensus
Strong Buy
26
Analysts
High
Coverage
Price Target
Analyst Price Target
+246.4% upside
Low Target
$33.46
Average Target
$49.10
High Target
$61.24
Current Price
$14.18
Current
$14.18
$14.18
Target
$49.10
$49.10
$33.46
$49.10 avg
$61.24
Scenario Analysis
Bear Case
$33.46
136.0%
Low target
Base Case
$49.10
+246.4%
Avg target
Bull Case
$61.24
+332.0%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$35.34
-59.9% from high
52-Week Low
$12.12
+17.0% from low
Target vs 52W High
$49.10
+38.9% vs high
Next Earnings Report
May 12, 2026 · After Market Close
1d
tomorrow
EPS Est: $-0.56
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +27.8% |
| AMGN | Hold | 44 | 48% | $190.87 | -42.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +176.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +2.0% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.3% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -65.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -19.5% |
| INSM | Strong Buy | 28 | 96% | $143.40 | +41.5% |